{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-035864","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2026-08-03T21:24:41+00:00","discovered_at":"2026-08-03T21:26:00.639685+00:00","generated_at":"2026-08-03T21:26:09.013862+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lantern Pharma spins out AI platform as Open-Medicine AI, signs commercial licenses","bullets":["Lantern Pharma (LTRN) creates Open-Medicine AI as a separate company to commercialize its multi-agent AI co-scientist platform.","Commercial licensing agreements executed between Lantern and OMAI for withZeta.ai-related models, data, and assets.","Board approved; structure consistent with May 2026 registered direct financing led by Empery Asset Management.","OMAI to expand beyond oncology into other disease areas; global AI drug discovery market projected >$10B by 2030.","AI Center of Excellence in Bengaluru, India established in Q1 2026 to support platform scaling."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-035864","json":"https://secwatch.observer/filing/0001493152-26-035864.json","markdown":"https://secwatch.observer/filing/0001493152-26-035864.md","text":"https://secwatch.observer/filing/0001493152-26-035864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226035864/0001493152-26-035864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226035864/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T21:26:09.013862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}